Introduction
Over the past decades, the rates of placenta accreta, and the related placenta increta and percreta, have been rising rapidly. In 1970s, the incidence of placenta accreta was 1 in 4027 pregnancies, which increased to 1 in 2510 in the 1980s and 1 in 533 during , as reported by Wu et al. [1] . Well-developed ultrasound and magnetic resonance imaging (MRI) imaging techniques have facilitated the prenatal diagnosis of placenta accreta, which allows the development of multidisciplinary management strategies to achieve the best outcomes for the mother and newborn [2] . However, there is no intervention available to reverse or even slow down the progression of abnormal placentation. Caesarean hysterectomy remains the mainstream management approach. Unfortunately, massive haemorrhage is frequent, resulting in greatly increased maternal morbidity and mortality [3, 4] .
As early as 1997, prophylactic placement of internal iliac artery balloons was reported to reduce blood loss during caesarean hysterectomy in women with placenta percreta [5] . However, subsequent single-case reports and case series revealed conflicting results, as reported by Dilauro et al. [6] . The few retrospective studies were also flawed, either because of a limited number of cases reported or because of a very long case-collection period [7, 8] .
The risk major haemorrhage during caesarean section for placenta accreta has a significant impact on pre-operative preparation and intra-operative decisionmaking, and the role of iliac balloons in reducing haemorrhage is of great importance to anaesthetists.
In November 2013, prophylactic placement of internal iliac artery balloon catheters was made routine for women with placenta accreta having caesarean section in our institution, whereas other aspects of management remained unchanged. We were therefore able to investigate the impact of this change on haemorrhage and transfusion requirements in these patients.
Methods
The study protocol was approved by the Ethics Committee of West China Second University Hospital. Individual consent was not deemed necessary as data were collected anonymously. We identified women admitted to our hospital between October 2012 and October 2014 with prenatally diagnosed placenta accreta, based on ultrasound and/or MRI, by searching our electronic medical record database with the following keywords: abnormal invasive placenta; placenta accreta; placenta increta; placenta percreta. From November 2013, all the women with a prenatal diagnosis of placenta accreta received prophylactic placement of iliac balloons. Women who had placenta accreta in the preceding 12 months from October 2012 to October 2013 served as controls. The peripartum management did not change over the time period apart from the use of iliac artery balloons. As the placement of iliac artery balloons was not available for emergency caesarean section, only elective cases were analysed.
The procedure for the management of iliac artery balloon catheters was as follows. On the day of surgery, the woman was first transferred to the interventional operating theatre for insertion of the catheters (low-profile PTA balloon dilatation catheter PTA5-35-80-8-6.0; Cook Medical Inc., Bloomington, IN, USA) under fluoroscopic guidance. The procedure was performed by one of two senior interventional radiologists, who each had more than five years of experience with the similar procedure of uterine artery embolisation for caesarean scar ectopic pregnancy. Catheters were inserted bilaterally via the femoral arteries under local anaesthesia, and the tip placed at the anterior division of the internal iliac artery. The balloon was briefly inflated, and contrast injected to verify occlusion of the artery. After placement of the catheters, the woman was transferred to the obstetric operating theatre. The peri-operative management was at the discretion of the assigned anaesthetist, but intra-arterial blood pressure monitoring was used in all cases. Blood transfusion was triggered at a haemoglobin level < 70 g.l
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. Primary outcomes included estimated intraoperative blood loss, amount of intra-operative and postpartum blood transfusion, and rate of caesarean hysterectomy. Blood loss was determined by weighing surgical sponges and measuring suction drainage. Secondary outcomes included duration of surgery, length of ICU stay, length of postoperative hospital stay and neonatal Apgar scores. Maternal complications related to balloon catheterisation were also recorded.
Statistical analysis was performed using the Mann-Whitney U-test and chi-squared test. Statistical analysis was performed using SPSS (version 20.0; SPSS Inc, Chicago, IL, USA). A p value < 0.05 was considered statistically significant.
Results
Forty-one eligible subjects were identified using our search criteria, including 11 controls and 30 women who had prophylactic balloon catheter placement, with balloon inflation in 27 cases (90%).
Maternal and fetal characteristics were similar between the two groups, including the severity of placenta accreta (Table 1 ). All women had had a caesarean section previously. Insertion of iliac artery balloons had a significant influence on the choice of anaesthetic technique, as five controls received spinal anaesthesia, whereas all women with iliac artery balloons received general anaesthesia (p = 0.001).
There was no difference in the intra-operative estimated blood loss (p = 0.64), or red blood cell transfusion volumes (p = 0.67) between the two groups ( Fig. 1 ). There were no differences in other aspects of blood loss or blood product transfusion between the two groups, both intra-and postoperatively (Table 2) , or in surgical techniques (Table 3) .
There were no severe complications related to the insertion of balloon catheters, although one woman developed a subcutaneous haematoma at the catheter insertion site. The women in the control group had a longer postoperative hospital stay, 6 (5-7 [4] [5] [6] [7] [8] [9] [10] [11] [12] ) days, compared with 5 (4-6 [3] [4] [5] [6] [7] [8] [9] [10] ) days for women with iliac artery balloons (p = 0.033).
Discussion
In this study, prophylactic insertion of internal iliac arterial balloons failed to reduce peripartum blood loss, requirement for blood transfusion or the incidence of caesarean hysterectomy in parturients with placenta accreta. However, insertion of iliac artery balloons was associated with reduced length of postoperative hospital stay.
Although advances in obstetric care have led to a substantial improvement in pregnancy outcomes, the death rate from placenta accreta remains as high as 7%, largely due to massive haemorrhage [9, 10] . Average blood loss has been estimated at 3-5 litres [11] ; 90% of patients require blood transfusion, while 40% require more than 10 units of red blood cells. Massive transfusion may then lead to disseminated intravascular coagulation, fluid overload, acute respiratory distress syndrome and infection.
Surgical ligation of the uterine arteries is effective in reducing placenta accreta-related haemorrhage [12] . However, it is not performed until massive blood loss has occurred, when it is challenging to identify and isolate the vessels, especially with the distorted anatomy caused by the gravid uterus. It seems logical that occlusion of the internal iliac arteries with prophylactically-placed balloon catheters would be a more effective treatment option, but reported results are controversial. Most of the positive results were from case reports, but because of publication bias and lack of proper controls, these should be interpreted with caution [13] [14] [15] . On the other hand, both positive [7, 8] and negative results [16, 17] have been reported in previous retrospective studies. Ballas et al. published the largest case-control comparison to date, with data spanning over 20 years [8] . They reported that insertion of iliac artery balloons was associated with reduced blood loss and need for massive transfusion. However, other changes in management will have occurred over this time period, such as advances in imaging technology [18] , electrosurgical instruments [19] , the B-Lynch suture, Bakri balloon and uterine artery embolisation [20] [21] [22] , and these may have contributed to the improved outcomes. Similarly, a recently reported randomised, controlled trial took more than seven years but only collected 27 women; the superiority of prophylactic balloon catheters in reducing transfusion or blood loss was not demonstrated [23] . In our present study, the study period was shortened to 24 months, and all women received the same standard peripartum care apart from the insertion of iliac artery balloons. There was almost three times the number of women in the treatment group, compared with the controls. This is partially due to the end of the 'one-child' policy in November 2013. The annual number of deliveries increased by 22.5%, from 9193 in the first half of the study period to 11,264 in the second half. Considering the high caesarean section rate in China [24] , a history of previous caesarean section is common in women who have a second baby, which will also result in a disproportionate increase in the rate of placenta accreta. It is unclear why occlusion of the internal iliac arteries failed to reduce haemorrhage in our study. The uterine arteries account for most of the blood supply to the uterus, but the extensive collateral supply from the ovarian arteries will not be affected [25] . Occlusion of the abdominal aorta, as suggested by Panici et al. [26] , may be a more effective strategy to reduce blood flow to the gravid uterus. However, severe complications, such as arterial thrombosis in the legs and femoral nerve ischaemic injury, were reported in a case series of 45 women receiving abdominal aortic balloons [27] . This casts doubts on the safety of this procedure, and further evaluation is urgently needed.
Another explanation for the failure of iliac artery balloons to reduce haemorrhage might be balloon migration. Two confirmed cases of balloon migration were identified in a cohort of 27 women receiving iliac artery balloons [28] . As the women were transferred from the interventional unit to the operating theatre after balloon insertion, and we were unable to perform real-time balloon imaging during the caesarean section, the possibility of balloon migration cannot be excluded.
Our results showed that insertion of iliac artery balloons reduced the length of postoperative hospital stay. This should also be interpreted cautiously. The groups were not randomised, and the decision for patient discharge may have been affected by a bias in favour of iliac balloons. Moreover, there was also a change in the postoperative length of stay for all women having caesarean section, which decreased from 5 (4-7 days in the first half of the study period to 5 (4-6 [2-57]) days in the second half (p < 0.001).
Clearly, prophylactic placement of iliac artery balloons has a significant impact on the choice of anaesthetic techniques, as all the women with balloons received general anaesthesia, while 45% of women in the control group received spinal anaesthesia. There are two reasons for this. Firstly, the patient cannot flex her legs for spinal insertion with a femoral catheter in place. Secondly, heparin was used during balloon placement, and the fear of spinal haematoma may have led to avoidance of spinal anaesthesia. However, a prolonged period from induction of general anaesthesia until delivery of the fetus is not uncommon in these women who have had previous caesarean section, which may cause respiratory depression in the neonate. Therefore, the best anaesthetic regimen remains to be identified.
The main limitation of our study is its retrospective nature. Because subjects were not randomly allocated, selection bias may exist. However, we had thorough case ascertainment, and the two groups were well-balanced.
In conclusion, our study found that prophylactic balloon occlusion of the internal iliac arteries is a safe procedure for the woman and fetus, but it failed to reduce intra-operative haemorrhage or caesarean hysterectomy in women with placenta accreta. 
